Home  >  Products  >  Eif4a1 (eukaryotic translation initiation factor 4A1 ) Blocking Peptide (the C terminal of Eif4a1)(100ug)
Eif4a1 (eukaryotic translation initiation factor 4A1 ) Blocking Peptide (the C terminal of Eif4a1)(100ug)

Eif4a1 (eukaryotic translation initiation factor 4A1 ) Blocking Peptide (the C terminal of Eif4a1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-Eif4a1 Antibody (ARP61945_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human, Mouse
Presku: AAP61945
Size: 100ug
Weight: 46kDa
Gene: 13681
Format: Lyophilized powder
Target: Eif4a1 is a ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon.
Alternative names: BM-010; Ddx2a; Eif4
See Full Product Listings >